/Investor DB

Nueterra Capital — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

BrainCheckbraincheck.comin𝕏Nov 2021

BrainCheck offers a platform for cognitive assessment and care planning, centered on an FDA-registered Class II digital cognitive assessment plus over 30 clinical evaluation tools that integrate into clinical workflows and EHR systems like Epic and athenahealth.

Digital HealthHealthtechMedical DevicesSaaSHouston, US

Yael Katz(Executive Officer, Director)inDavid Eagleman(Executive Officer, Director)inAndrew Chen(Founder)in

Co-investorsBlue Hour VenturesGOOSE CapitalNext Coast VenturesS3 VenturesTensility Venture PartnersTrue Wealth Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.